关注
Neus Bota-Rabassedas
Neus Bota-Rabassedas
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pathology and classification of SCLC
MG Raso, N Bota-Rabassedas, II Wistuba
Cancers 13 (4), 820, 2021
1162021
Cancer becomes wasteful: emerging roles of exosomes in cell-fate determination
F Wendler, N Bota-Rabassedas, X Franch-Marro
Journal of extracellular vesicles 2 (1), 22390, 2013
762013
Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth
C Barceló, N Paco, M Morell, B Alvarez-Moya, N Bota-Rabassedas, ...
Cancer research 74 (4), 1190-1199, 2014
732014
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma
X Tan, P Banerjee, EA Pham, FUN Rutaganira, K Basu, ...
Science Translational Medicine 12 (527), 2020
522020
Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding
HF Guo, CL Tsai, M Terajima, X Tan, P Banerjee, MD Miller, X Liu, J Yu, ...
Nature communications 9 (1), 512, 2018
482018
Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer
M Yamauchi, DL Gibbons, C Zong, JJ Fradette, N Bota-Rabassedas, ...
Matrix biology 91, 8-18, 2020
462020
Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis
MJ Schliekelman, CJ Creighton, BN Baird, Y Chen, P Banerjee, ...
Scientific reports 7 (1), 6478, 2017
462017
The ISG15-specific protease USP18 regulates stability of PTEN
LM Mustachio, M Kawakami, Y Lu, J Rodriguez-Canales, B Mino, ...
Oncotarget 8 (1), 3, 2017
442017
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma
X Tan, L Shi, P Banerjee, X Liu, HF Guo, J Yu, N Bota-Rabassedas, ...
The Journal of Clinical Investigation 131 (1), 2021
312021
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells
P Banerjee, GY Xiao, X Tan, VJ Zheng, L Shi, MNB Rabassedas, H Guo, ...
Nature communications 12 (1), 6354, 2021
262021
Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity
N Bota-Rabassedas, P Banerjee, Y Niu, W Cao, J Luo, Y Xi, X Tan, ...
Cell reports 35 (3), 2021
212021
International association for the study of lung cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy
S Dacic, W Travis, M Redman, A Saqi, WA Cooper, A Borczuk, JH Chung, ...
Journal of Thoracic Oncology 18 (10), 1290-1302, 2023
192023
A collagen glucosyltransferase drives lung adenocarcinoma progression in mice
HF Guo, N Bota-Rabassedas, M Terajima, B Leticia Rodriguez, ...
Communications biology 4 (1), 482, 2021
182021
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21. 3–amplified lung adenocarcinoma cells
L Shi, X Tan, X Liu, J Yu, N Bota-Rabassedas, Y Niu, J Luo, Y Xi, C Zong, ...
Proceedings of the National Academy of Sciences 118 (25), e2023537118, 2021
152021
Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy, and chemoimmunotherapy in resectable NSCLC
P Rocha, J Zhang, R Laza-Briviesca, A Cruz-Bermúdez, ...
Clinical Cancer Research 28 (11), 2461-2473, 2022
122022
FGF coordinates air sac development by activation of the EGF ligand Vein through the transcription factor PntP2
J Cruz, N Bota-Rabassedas, X Franch-Marro
Scientific reports 5 (1), 17806, 2015
122015
Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment
S Dacic, X Cao, N Bota-Rabassedas, B Sanchez-Espiridion, ...
Journal of Thoracic Oncology 19 (2), 273-284, 2024
72024
Pathology and classification of SCLC. Cancers. 2021; 13 (4): 820
MG Raso, N Bota-Rabassedas, II Wistuba
DOI: https://doi. org/10.3390/cancers13040820, 0
5
Use of osteoblast-derived matrix to assess the influence of collagen modifications on cancer cells
N Bota-Rabassedas, HF Guo, P Banerjee, Y Chen, M Terajima, ...
Matrix biology plus 8, 100047, 2020
32020
系统目前无法执行此操作,请稍后再试。
文章 1–19